203 related articles for article (PubMed ID: 19327620)
1. Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.
McNamara DM; Tam SW; Sabolinski ML; Tobelmann P; Janosko K; Venkitachalam L; Ofili E; Yancy C; Feldman AM; Ghali JK; Taylor AL; Cohn JN; Worcel M
J Card Fail; 2009 Apr; 15(3):191-8. PubMed ID: 19327620
[TBL] [Abstract][Full Text] [Related]
2. G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT.
McNamara DM; Taylor AL; Tam SW; Worcel M; Yancy CW; Hanley-Yanez K; Cohn JN; Feldman AM
JACC Heart Fail; 2014 Dec; 2(6):551-7. PubMed ID: 25306451
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial.
McNamara DM; Tam SW; Sabolinski ML; Tobelmann P; Janosko K; Taylor AL; Cohn JN; Feldman AM; Worcel M
J Am Coll Cardiol; 2006 Sep; 48(6):1277-82. PubMed ID: 16979018
[TBL] [Abstract][Full Text] [Related]
4. Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
Taylor AL; Ziesche S; Yancy CW; Carson P; Ferdinand K; Taylor M; Adams K; Olukotun AY; Ofili E; Tam SW; Sabolinski ML; Worcel M; Cohn JN;
Circulation; 2007 Apr; 115(13):1747-53. PubMed ID: 17372175
[TBL] [Abstract][Full Text] [Related]
5. Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.
Cohn JN; Tam SW; Anand IS; Taylor AL; Sabolinski ML; Worcel M;
J Card Fail; 2007 Jun; 13(5):331-9. PubMed ID: 17602978
[TBL] [Abstract][Full Text] [Related]
6. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN;
Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
[TBL] [Abstract][Full Text] [Related]
7. Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trial.
Taylor AL; Sabolinski ML; Tam SW; Ziesche S; Ghali JK; Archambault WT; Worcel M; Cohn JN;
J Card Fail; 2012 Aug; 18(8):600-6. PubMed ID: 22858074
[TBL] [Abstract][Full Text] [Related]
8. Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial.
Anand IS; Tam SW; Rector TS; Taylor AL; Sabolinski ML; Archambault WT; Adams KF; Olukotun AY; Worcel M; Cohn JN
J Am Coll Cardiol; 2007 Jan; 49(1):32-9. PubMed ID: 17207719
[TBL] [Abstract][Full Text] [Related]
9. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT).
Carson P; Johnson G; Fletcher R; Cohn J
J Am Coll Cardiol; 1996 Mar; 27(3):642-9. PubMed ID: 8606276
[TBL] [Abstract][Full Text] [Related]
10. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
Taylor AL; Ziesche S; Yancy C; Carson P; D'Agostino R; Ferdinand K; Taylor M; Adams K; Sabolinski M; Worcel M; Cohn JN;
N Engl J Med; 2004 Nov; 351(20):2049-57. PubMed ID: 15533851
[TBL] [Abstract][Full Text] [Related]
11. African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology.
Franciosa JA; Taylor AL; Cohn JN; Yancy CW; Ziesche S; Olukotun A; Ofili E; Ferdinand K; Loscalzo J; Worcel M;
J Card Fail; 2002 Jun; 8(3):128-35. PubMed ID: 12140804
[TBL] [Abstract][Full Text] [Related]
12. Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.
Echols MR; Yancy CW
Vasc Health Risk Manag; 2006; 2(4):423-31. PubMed ID: 17323596
[TBL] [Abstract][Full Text] [Related]
13. A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination.
Cheng JW
Clin Ther; 2006 May; 28(5):666-78. PubMed ID: 16861089
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.
Carson P; Ziesche S; Johnson G; Cohn JN
J Card Fail; 1999 Sep; 5(3):178-87. PubMed ID: 10496190
[TBL] [Abstract][Full Text] [Related]
15. Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial.
Ferdinand KC; Elkayam U; Mancini D; Ofili E; Piña I; Anand I; Feldman AM; McNamara D; Leggett C
Am J Cardiol; 2014 Jul; 114(1):151-9. PubMed ID: 24846808
[TBL] [Abstract][Full Text] [Related]
16. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
Golwala HB; Thadani U; Liang L; Stavrakis S; Butler J; Yancy CW; Bhatt DL; Hernandez AF; Fonarow GC
J Am Heart Assoc; 2013 Aug; 2(4):e000214. PubMed ID: 23966379
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT).
Mitchell JE; Tam SW; Trivedi K; Taylor AL; O'Neal W; Cohn JN; Worcel M
Am Heart J; 2011 Jul; 162(1):154-9. PubMed ID: 21742102
[TBL] [Abstract][Full Text] [Related]
18. The African American Heart Failure Trial: a clinical trial update.
Taylor AL
Am J Cardiol; 2005 Oct; 96(7B):44-8. PubMed ID: 16226935
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
Hammermeister KE; Fairclough D; Emsermann CB; Hamman R; Ho M; Phibbs S; Plomondon M; Valuck R; West D; Steiner JF
Clin Ther; 2009 Mar; 31(3):632-43. PubMed ID: 19393854
[TBL] [Abstract][Full Text] [Related]
20. Endothelial nitric oxide synthase Glu298Asp gene polymorphism in a multi-ethnical population with heart failure and controls.
Velloso MW; Pereira SB; Gouveia L; Chermont S; Tardin OM; Gonçalves R; Camacho V; Contarato Lde F; Quintão M; Oliveira e Alves T; Pessoa LP; Brito Júnior A; Ribeiro GS; Mesquita ET
Nitric Oxide; 2010 Apr; 22(3):220-5. PubMed ID: 20079452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
